Podcasts

Episode 7 | Lung cancer screening works!

In this episode, Prof Emily Stone and Prof Kwun Fong, both long time advocates and researchers in early screening discuss the challenges of implementing a lung cancer screening program.

Lung cancer screening works!

Episode Summary

In this episode Prof Emily Stone interviews Prof Kwun Fong to discuss the challenges of implementing a lung cancer screening program. Both are long time advocates and researchers in early screening for lung cancer. Lung cancer screening works. Earlier detection of lung cancer presents a vastly different prognosis. Stage I disease has a median 5 year survival of greater than 65%, whereas metastatic disease has a 5 year median survival rate of 15-20%. It is time to shift the perception of a lung cancer diagnosis to that of a treatable cancer with a potential cure, through a combination of early-stage detection, and effective communication that newer treatments offer better survival and QoL. The recently released Cancer Australia Report on lung cancer screening has been presented to the Health Minister and is awaiting actions.

Show Hosts

This episode’s host are:

  • Prof Emily Stone, Deputy Chair, TOGA; Respiratory Physician, Senior Staff Specialist and Head of Thoracic Medicine, Department of Thoracic Medicine and Lung Transplantation, St Vincent’s Hospital Sydney; conjoint Senior Lecturer, University of New South Wales; Chair, St Vincent’s Hospital Lung Cancer Multidisciplinary team
  • Prof Kwun Fong, Thoracic and Sleep Physician, The Prince Charles Hospital

Play Episode 7 | Lung cancer screening works!

More Podcasts

A conversation with Associate Professor Tom John and Professor Ben Solomon where they discuss the increased survival benefits for patients with oncogene driven lung cancer
In this Podcast, Mark Scott talks with Alexandra Golledge about her challenges in diagnosis, searching for the best treatments available, living in a regional area
Prof Nick Pavlakis and Prof Emily Stone join discuss the remarkable advances in screening, diagnosing and treating lung cancer that occurred during 2020.
Dorothy Keefe, CEO of Cancer Australia and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients.
A fireside chat with Prunella Blinman, Shankar Siva and our three Preceptees: Anna Lawless, Abhijit Pal and Melanie Rabbets about their experiences, their learnings, what
In this episode, Prof Anna Nowak and A/Prof Steven Kao discuss the emerging treatments for mesothelioma patients and the DREAM3R trial.